Cargando…

T- and B-cell responses to multivalent prime-boost DNA and viral vectored vaccine combinations against hepatitis C virus in non-human primates

Immune responses against multiple epitopes are required for the prevention of hepatitis C virus (HCV) infection, and the progression to phase I trials of candidates may be guided by comparative immunogenicity studies in non-human primates. Four vectors, DNA, SFV, human serotype 5 adenovirus (HuAd5)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rollier, C S, Verschoor, E J, Verstrepen, B E, Drexhage, J A R, Paranhos-Baccala, G, Liljeström, P, Sutter, G, Arribillaga, L, Lasarte, J J, Bartosch, B, Cosset, F-L, Inchauspe, G, Heeney, J L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7091906/ https://www.ncbi.nlm.nih.gov/pubmed/27416077 http://dx.doi.org/10.1038/gt.2016.55

Ejemplares similares

Clearance of Genotype 1b Hepatitis C Virus in Chimpanzees in the Presence of Vaccine-Induced E1-Neutralizing Antibodies
por: Verstrepen, Babs E., et al.
Publicado: (2011)

Macaques primed with self-amplifying RNA vaccines expressing HIV-1 envelope and boosted with recombinant protein show potent T- and B-cell responses
por: Bogers, WM, et al.
Publicado: (2012)

Immunogenicity of Low-Dose Prime-Boost Vaccination of mRNA Vaccine CV07050101 in Non-Human Primates
por: van Doremalen, Neeltje, et al.
Publicado: (2021)

Immunogenicity of low dose prime-boost vaccination of mRNA vaccine CV07050101 in non-human primates
por: van Doremalen, Neeltje, et al.
Publicado: (2021)

Ebola-GP DNA Prime rAd5-GP Boost: Influence of Prime Frequency and Prime/Boost Time Interval on the Immune Response in Non-human Primates
por: Marcus, Hadar, et al.
Publicado: (2021)

Dosimetric evaluation and radioimmunotherapy of anti-tumour multivalent Fab́ fragments
por: Casey, J L, et al.
Publicado: (1999)

Strong Vaccine-Induced CD8 T-Cell Responses Have Cytolytic Function in a Chimpanzee Clearing HCV Infection
por: Verstrepen, Babs E., et al.
Publicado: (2014)

Priming T-cell responses with recombinant measles vaccine vector in a heterologous prime-boost setting in non-human primates
por: Bolton, Diane L., et al.
Publicado: (2012)

Resolution of Eczema with Multivalent Peptides
por: Eggink, Laura L., et al.
Publicado: (2022)

Delineating the prime mover action of progesterone for endometrial receptivity in primates
por: Ghosh, D., et al.
Publicado: (2014)

Alphavirus Replicon DNA Expressing HIV Antigens Is an Excellent Prime for Boosting with Recombinant Modified Vaccinia Ankara (MVA) or with HIV gp140 Protein Antigen
por: Knudsen, Maria L., et al.
Publicado: (2015)

Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes
por: Bartosch, Birke, et al.
Publicado: (2003)

Multivalent weak interactions enhance selectivity of interparticle binding
por: Scheepers, M. R. W., et al.
Publicado: (2020)

Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates
por: Wille-Reece, Ulrike, et al.
Publicado: (2006)

Multivalency regulates activity in an intrinsically disordered transcription factor
por: Clark, Sarah, et al.
Publicado: (2018)

Multivalency regulates activity in an intrinsically disordered transcription factor
por: Clark, Sarah, et al.
Publicado: (2018)

Serological Detection of Ebola Virus Exposures in Native Non-human Primates of Southern Nigeria
por: Ogunro, B.N., et al.
Publicado: (2018)

Pinpointing the PRDM9-PRDM7 Gene Duplication Event During Primate Divergence
por: Heerschop, Sacha, et al.
Publicado: (2021)

Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates
por: Walters, Jewell N., et al.
Publicado: (2022)

Multivalency: concepts, research and applications
por: Huskens, Jurriaan, et al.
Publicado: (2017)

Factoring semi-primes with (quantum) SAT-solvers
por: Mosca, Michele, et al.
Publicado: (2022)

A Heterologous Prime/Boost Vaccination Strategy Enhances the Immunogenicity of Therapeutic Vaccines for Hepatitis C Virus
por: Fournillier, Anne, et al.
Publicado: (2013)

P19-05. Use of autologous apoptotic pseudovirus infected cells for vaccination against HIV, evaluation in macaques
por: Koopman, G, et al.
Publicado: (2009)

Multivalent Viral Capsids with Internal Cargo for Fibrin Imaging
por: Obermeyer, Allie C., et al.
Publicado: (2014)

An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
por: Harari, Alexandre, et al.
Publicado: (2008)

Multivalent scaffolds induce galectin-3 aggregation into nanoparticles
por: Goodman, Candace K, et al.
Publicado: (2014)

Prime-boost regimen potency and efficacy with alphavirus replicons (SIV antigen) in non-human primates challenged with low-dose intra-rectal SIVsmE660
por: Banerjee, K, et al.
Publicado: (2012)

Multivalency in a Dendritic Host–Guest System
por: Smeijers, A. F., et al.
Publicado: (2019)

In Vitro Neutralization of Low Dose Inocula at Physiological Concentrations of a Monoclonal Antibody Which Protects Macaques against SHIV Challenge
por: Davis, David, et al.
Publicado: (2013)

Theory of Surface Forces in Multivalent Electrolytes
por: Misra, Rahul Prasanna, et al.
Publicado: (2019)

Immunogenicity and protectivity of intranasally delivered vector-based heterologous prime-boost COVID-19 vaccine Sputnik V in mice and non-human primates
por: Tukhvatulin, Amir I., et al.
Publicado: (2022)

Multivalency Enables Dynamic Supramolecular Host–Guest Hydrogel Formation
por: Ooi, Huey Wen, et al.
Publicado: (2020)

Qualitative differences in cellular immunogenicity elicited by hepatitis C virus T-Cell vaccines employing prime-boost regimens
por: Tan, Wendy G., et al.
Publicado: (2017)

Controlling T-Cell Activation with Synthetic Dendritic Cells Using the Multivalency Effect
por: Hammink, Roel, et al.
Publicado: (2017)

Design of Multivalent Inhibitors for Preventing Cellular Uptake
por: Schubertová, Veronika, et al.
Publicado: (2017)

A combined adjuvant approach primes robust germinal center responses and humoral immunity in non-human primates
por: Phung, Ivy, et al.
Publicado: (2023)

EFFECTOR CELL BLOCKADE : A NEW MECHANISM OF IMMUNE HYPOREACTIVITY INDUCED BY MULTIVALENT ANTIGENS
por: Schrader, John W., et al.
Publicado: (1974)

Multivalent interactions essential for lentiviral integrase function
por: Ballandras-Colas, Allison, et al.
Publicado: (2022)

Multivalent glycosystems for nanoscience
por: Lindhorst, Thisbe K
Publicado: (2014)

Nanoscale Peptide Self-assemblies Boost BCG-primed Cellular Immunity Against Mycobacterium tuberculosis
por: Chesson, Charles B., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ebg6r0b583iqkln8i0f93t05ph